Cg Oncology Inc (NASDAQ:CGON) price on Friday, June 13, fall -2.42% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $25.86.
A look at the stock’s price movement, the close in the last trading session was $26.50. Turning to its 52-week performance, $40.47 and $14.80 were the 52-week high and 52-week low respectively. Overall, CGON moved 6.99% over the past month.
Cg Oncology Inc’s market cap currently stands at around $1.97 billion, with investors looking forward to this quarter’s earnings report slated for in July.
4 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 4 recommend CGON as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CGON’s current price about -1.19% and 8.59% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 50.37, while 7-day volatility ratio is 3.13% and 2.57% in the 30-day chart. Further, Cg Oncology Inc (CGON) has a beta value of 0.88, and an average true range (ATR) of 1.45. Analysts have given the company’s stock an average 52-week price target of $55, forecast between a low of $55 and high of $55. Looking at the price targets, the low is -112.68% off current price level while to achieve the yearly target high, price needs to move -112.68%. Nonetheless, investors will most likely welcome a -112.68% jump to $55 which is the analysts’ median price.
If we refocus on Cg Oncology Inc (NASDAQ:CGON), historical trading data shows that trading volumes averaged 1.37 million over the past 3 months. The company’s latest data on shares outstanding shows there are 76.22 million shares.
The 41.12% of Cg Oncology Inc’s shares are in the hands of company insiders while institutional holders own 68.21% of the company’s shares. Current price change has pushed the stock -9.83% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CGON stock continues to rise going into the next quarter.
